mayo clinic glp 1 program A study found that both metabolic and bariatric surgery and GLP- medications improve cardiovascular health in people with obesity, but surgery was associated with significantly greater reductions in long-term cardiovascular Mayo Clinic Diet: How She

The study, conducted using electronic health records from the TriNetX network between 2017 and 2024, excluded patients with prior neurodegenerative or cerebrovascular conditions and used propensity score matching to balance baseline characteristics

Who Benefits Most from GLP-1

Sitagliptin phosphate: A DPP-4 inhibitor for the treatment of type 2 diabetes mellitus

This allows for greater flexibility in dosing or combinations, which may not be available with the standard commercial formulation

If you are breastfeeding or planning to become pregnant, discuss timing with your provider before switching

These medications may not be suitable for individuals with: A personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2)